Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2008

01-02-2008 | Original Article

Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review

Authors: Marie D. Philipneri, Lisa A. Rocca Rey, Mark A. Schnitzler, Kevin C. Abbott, Daniel C. Brennan, Steven K. Takemoto, Paula M. Buchanan, Thomas E. Burroughs, Lisa M. Willoughby, Krista L. Lentine

Published in: Clinical and Experimental Nephrology | Issue 1/2008

Login to get access

Abstract

Background

Clinical practice guidelines for management of chronic kidney disease (CKD) have been developed within the Kidney Disease Outcomes Quality Initiative (K/DOQI). Adherence patterns may identify focus areas for quality improvement.

Methods

We retrospectively studied contemporary CKD care patterns within a private health system in the United States, and systematically reviewed literature of reported practices internationally. Five hundred and nineteen patients with moderate CKD (estimated GFR 30–59 ml/min) using healthcare benefits in 2002–2005 were identified from administrative insurance records. Thirty-three relevant publications in 2000–2006 describing care in 77,588 CKD patients were reviewed. Baseline demographic traits and provider specialty were considered as correlates of delivered care. Testing consistent with K/DOQI guidelines and prevalence of angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB) medication prescriptions were ascertained from billing claims. Care descriptions in the literature sample were based on medical charts, electronic records and/or claims.

Results

KDOQI-consistent measurements of parathyroid hormone (7.1 vs. 0.6%, P = 0.0002), phosphorus (38.2 vs. 1.9%, P < 0.0001) and quantified urinary protein (23.8 vs. 9.4%, P = 0.008) were more common among CKD patients with versus without nephrology referral in the administrative data. Nephrology referral correlated with increased likelihood of testing for parathyroid hormone and phosphorus after adjustment for baseline patient factors. Use of ACEi/ARB medications was more common among patients with nephrology contact (50.0 vs. 30.0%; P = 0.008) but appeared largely driven by higher comorbidity burden. The literature review demonstrated similar practice patterns.

Conclusions

Delivery of CKD care may be monitored by administrative data. There is opportunity for improvement in CKD guideline adherence in practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1–12.CrossRefPubMed Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1–12.CrossRefPubMed
3.
go back to reference Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Inter Med. 2005;142(5):342–51.CrossRef Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Inter Med. 2005;142(5):342–51.CrossRef
4.
go back to reference Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354(9176):359–64.CrossRefPubMed Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354(9176):359–64.CrossRefPubMed
5.
go back to reference Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Inter Med. 2003;139(4):244–52.CrossRef Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Inter Med. 2003;139(4):244–52.CrossRef
6.
go back to reference Kausz AT, Khan SS, Abichandani R, Kazmi WH, Obrador GT, Ruthazer R, et al. Management of patients with chronic renal insufficiency in the Northeastern United States. J Am Soc Nephrol. 2001;12(7):1501–7.PubMed Kausz AT, Khan SS, Abichandani R, Kazmi WH, Obrador GT, Ruthazer R, et al. Management of patients with chronic renal insufficiency in the Northeastern United States. J Am Soc Nephrol. 2001;12(7):1501–7.PubMed
7.
go back to reference Winkelmayer WC, Levin R, Avorn J. The nephrologist’s role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003;63(5):1836–42.CrossRefPubMed Winkelmayer WC, Levin R, Avorn J. The nephrologist’s role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003;63(5):1836–42.CrossRefPubMed
8.
go back to reference Lafayette RA, Lai G. Examining chronic kidney disease management in a single center. Clin Nephrol. 2004;62(4):260–6.CrossRefPubMed Lafayette RA, Lai G. Examining chronic kidney disease management in a single center. Clin Nephrol. 2004;62(4):260–6.CrossRefPubMed
9.
go back to reference Kausz AT, Guo H, Pereira BJ, Collins AJ, Gilbertson DT. General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol. 2005;16(10):3092–101.CrossRefPubMed Kausz AT, Guo H, Pereira BJ, Collins AJ, Gilbertson DT. General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol. 2005;16(10):3092–101.CrossRefPubMed
10.
go back to reference Murray BM, Malireddi K, Vavilala V. Delivery of predialysis care in an academic referral nephrology practice. Ren Fail. 2005;27(5):571–80.CrossRefPubMed Murray BM, Malireddi K, Vavilala V. Delivery of predialysis care in an academic referral nephrology practice. Ren Fail. 2005;27(5):571–80.CrossRefPubMed
11.
go back to reference National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
12.
go back to reference Avorn J, Bohn RL, Levy E, Levin R, Owen WF Jr, Winkelmayer WC, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Inter Med. 2002;162(17):2002–6.CrossRef Avorn J, Bohn RL, Levy E, Levin R, Owen WF Jr, Winkelmayer WC, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Inter Med. 2002;162(17):2002–6.CrossRef
13.
go back to reference Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Inter Med. 2002;137(6):479–86.CrossRef Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Inter Med. 2002;137(6):479–86.CrossRef
14.
go back to reference Obrador GT, Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31(3):398–417.CrossRefPubMed Obrador GT, Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31(3):398–417.CrossRefPubMed
15.
go back to reference De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69(3):538–45.CrossRefPubMed De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69(3):538–45.CrossRefPubMed
16.
go back to reference Israni A, Korzelius C, Townsend R, Mesler D. Management of chronic kidney disease in an academic primary care clinic. Am J Nephrol. 2003;23(1):47–54.CrossRefPubMed Israni A, Korzelius C, Townsend R, Mesler D. Management of chronic kidney disease in an academic primary care clinic. Am J Nephrol. 2003;23(1):47–54.CrossRefPubMed
18.
go back to reference Saelen MG, Prosch LK, Gudmundsdottir H, Dyrbekk D, Helge Hunderi O, Arnesen E, et al. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function. Blood Press. 2005;14(3):170–6.CrossRefPubMed Saelen MG, Prosch LK, Gudmundsdottir H, Dyrbekk D, Helge Hunderi O, Arnesen E, et al. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function. Blood Press. 2005;14(3):170–6.CrossRefPubMed
19.
go back to reference National Kidney F. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1–201. National Kidney F. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1–201.
20.
go back to reference Kidney Disease Outcomes Quality Initiative G. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis. 2003;41(4 Suppl 3):I–IV. Kidney Disease Outcomes Quality Initiative G. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis. 2003;41(4 Suppl 3):I–IV.
21.
go back to reference de Lusignan S, Chan T, Stevens P, O’Donoghue D, Hague N, Dzregah B, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract. 2005;22(3):234–41.CrossRefPubMed de Lusignan S, Chan T, Stevens P, O’Donoghue D, Hague N, Dzregah B, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract. 2005;22(3):234–41.CrossRefPubMed
22.
go back to reference Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005;16(8):2439–48.CrossRefPubMed Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005;16(8):2439–48.CrossRefPubMed
23.
go back to reference Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency. (see comment). Am J Hypertens. 2001;14(12):1219–25.CrossRefPubMed Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency. (see comment). Am J Hypertens. 2001;14(12):1219–25.CrossRefPubMed
24.
go back to reference Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, Ethier J, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis. 2001;38(6):1398–407.CrossRefPubMed Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, Ethier J, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis. 2001;38(6):1398–407.CrossRefPubMed
25.
go back to reference Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol. 2001;12(8):1713–20.PubMed Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol. 2001;12(8):1713–20.PubMed
26.
go back to reference Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis. 2001;37(3):484–9.CrossRefPubMed Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis. 2001;37(3):484–9.CrossRefPubMed
27.
go back to reference Cleveland DR, Jindal KK, Hirsch DJ, Kiberd BA. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis. 2002;40(1):30–6.CrossRefPubMed Cleveland DR, Jindal KK, Hirsch DJ, Kiberd BA. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis. 2002;40(1):30–6.CrossRefPubMed
28.
go back to reference De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol. 2002;13(11):2762–9.CrossRefPubMed De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol. 2002;13(11):2762–9.CrossRefPubMed
29.
go back to reference Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJ, Kausz AT. Health care utilization among patients with chronic kidney disease. Kidney Int. 2002;62(1):229–36.CrossRefPubMed Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJ, Kausz AT. Health care utilization among patients with chronic kidney disease. Kidney Int. 2002;62(1):229–36.CrossRefPubMed
30.
go back to reference London R, Solis A, Goldberg GA, Wade S, Ryu S. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis. 2002;40(3):539–48.CrossRefPubMed London R, Solis A, Goldberg GA, Wade S, Ryu S. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis. 2002;40(3):539–48.CrossRefPubMed
31.
go back to reference Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA. Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant. 2002;17(8):1426–33.CrossRefPubMed Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA. Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant. 2002;17(8):1426–33.CrossRefPubMed
32.
go back to reference London R, Solis A, Goldberg GA, Wade S, Chan WW. Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population. J Manage Care Pharm. 2003;9(3):248–55. London R, Solis A, Goldberg GA, Wade S, Chan WW. Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population. J Manage Care Pharm. 2003;9(3):248–55.
33.
go back to reference Perlman RL, Kiser M, Finkelstein F, Eisele G, Roys E, Liu L, et al. The longitudinal chronic kidney disease study: a prospective cohort study of predialysis renal failure. Semin Dial. 2003;16(6):418–23.CrossRefPubMed Perlman RL, Kiser M, Finkelstein F, Eisele G, Roys E, Liu L, et al. The longitudinal chronic kidney disease study: a prospective cohort study of predialysis renal failure. Semin Dial. 2003;16(6):418–23.CrossRefPubMed
34.
go back to reference Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am College Cardiol. 2004;44(8):1587–92.CrossRef Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am College Cardiol. 2004;44(8):1587–92.CrossRef
35.
go back to reference McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. (see comment). Circulation. 2004;109(8):1004–9.CrossRefPubMed McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. (see comment). Circulation. 2004;109(8):1004–9.CrossRefPubMed
36.
go back to reference Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Inter Med. 2004;19(6):669–75.CrossRef Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Inter Med. 2004;19(6):669–75.CrossRef
37.
go back to reference So WY, Ozaki R, Chan NN, Tong PC, Ho CS, Lam CW, et al. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension. 2004;44(3):294–9.CrossRefPubMed So WY, Ozaki R, Chan NN, Tong PC, Ho CS, Lam CW, et al. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension. 2004;44(3):294–9.CrossRefPubMed
38.
go back to reference Bailie GR, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, et al. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant. 2005;20(6):1110–5.CrossRefPubMed Bailie GR, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, et al. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant. 2005;20(6):1110–5.CrossRefPubMed
39.
go back to reference De Nicola L, Minutolo R, Zamboli P, Cestaro R, Marzano L, Giannattasio P, et al. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study. Semin Nephrol. 2005;25(6):425–30.CrossRefPubMed De Nicola L, Minutolo R, Zamboli P, Cestaro R, Marzano L, Giannattasio P, et al. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study. Semin Nephrol. 2005;25(6):425–30.CrossRefPubMed
40.
go back to reference Leehey DJ, Kramer HJ, Daoud TM, Chatha MP, Isreb MA. Progression of kidney disease in type 2 diabetes—beyond blood pressure control: an observational study. BMC Nephrol. 2005;6(1):8.CrossRefPubMedPubMedCentral Leehey DJ, Kramer HJ, Daoud TM, Chatha MP, Isreb MA. Progression of kidney disease in type 2 diabetes—beyond blood pressure control: an observational study. BMC Nephrol. 2005;6(1):8.CrossRefPubMedPubMedCentral
41.
go back to reference Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, et al. Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis. 2005;46(1):18–25.CrossRefPubMed Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, et al. Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis. 2005;46(1):18–25.CrossRefPubMed
42.
go back to reference Thanamayooran S, Rose C, Hirsch DJ. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrol Dial Transplant. 2005;20(11):2385–93.CrossRefPubMed Thanamayooran S, Rose C, Hirsch DJ. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrol Dial Transplant. 2005;20(11):2385–93.CrossRefPubMed
43.
go back to reference Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005;46(6):1080–7.CrossRefPubMed Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005;46(6):1080–7.CrossRefPubMed
44.
go back to reference Jayapaul MK, Messersmith R, Bennett-Jones DN, Mead PA, Large DM. The joint diabetic-renal clinic in clinical practice: 10 years of data from a District General Hospital. Qjm. 2006;99(3):153–60.CrossRefPubMed Jayapaul MK, Messersmith R, Bennett-Jones DN, Mead PA, Large DM. The joint diabetic-renal clinic in clinical practice: 10 years of data from a District General Hospital. Qjm. 2006;99(3):153–60.CrossRefPubMed
45.
go back to reference Jones C, Roderick P, Harris S, Rogerson M. An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD. Am J Kidney Dis. 2006;47(1):103–14.CrossRefPubMed Jones C, Roderick P, Harris S, Rogerson M. An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD. Am J Kidney Dis. 2006;47(1):103–14.CrossRefPubMed
46.
go back to reference Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Inter Med. 2006;166(17):1884–91.CrossRef Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Inter Med. 2006;166(17):1884–91.CrossRef
47.
go back to reference Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant. 2006;21:2133–43.CrossRefPubMed Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant. 2006;21:2133–43.CrossRefPubMed
49.
go back to reference Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification, referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48(2):192–204.CrossRefPubMed Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification, referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48(2):192–204.CrossRefPubMed
50.
go back to reference Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis. 2006;47(1):72–7.CrossRefPubMed Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis. 2006;47(1):72–7.CrossRefPubMed
51.
go back to reference Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Inter Med. 2005;165(14):1637–42.CrossRef Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Inter Med. 2005;165(14):1637–42.CrossRef
52.
go back to reference Gilmer TP, O’Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28(1):59–64.CrossRefPubMed Gilmer TP, O’Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28(1):59–64.CrossRefPubMed
53.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med. 2004;351(13):1296–305.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med. 2004;351(13):1296–305.CrossRefPubMed
54.
go back to reference Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Inter Med. 2002;162(20):2269–76.CrossRef Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Inter Med. 2002;162(20):2269–76.CrossRef
55.
go back to reference Stirnemann PM, Takemoto SK, Schnitzler MA, Brennan DC, Abbott KC, Salvalaggio P, et al. Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol. 2006;17(8):2299–306.CrossRefPubMed Stirnemann PM, Takemoto SK, Schnitzler MA, Brennan DC, Abbott KC, Salvalaggio P, et al. Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol. 2006;17(8):2299–306.CrossRefPubMed
Metadata
Title
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review
Authors
Marie D. Philipneri
Lisa A. Rocca Rey
Mark A. Schnitzler
Kevin C. Abbott
Daniel C. Brennan
Steven K. Takemoto
Paula M. Buchanan
Thomas E. Burroughs
Lisa M. Willoughby
Krista L. Lentine
Publication date
01-02-2008
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2008
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-007-0016-3

Other articles of this Issue 1/2008

Clinical and Experimental Nephrology 1/2008 Go to the issue